- Fulgent Genetics (FLGT, Financial) to release Q1 2025 earnings on May 2, 2025.
- Earnings call scheduled for 8:30 AM ET on the same day.
- Live audio webcast and replay available on Fulgent's Investor Relations website.
Fulgent Genetics, Inc. (FLGT), a technology-driven company with a focus on laboratory and therapeutic development services, is set to announce its financial results for the first quarter of 2025. The announcement will be made before the market opens on Friday, May 2, 2025.
The company has organized a conference call for investors on the same day at 8:30 AM ET (5:30 AM PT). During the call, management will discuss the financial results and engage in a Q&A session. Interested stakeholders can access the live audio webcast of the call through the Investor Relations section on Fulgent's official website. An audio replay will be available post-call for those who cannot join live.
Fulgent Genetics operates a well-established laboratory services business along with a therapeutic development division. The company is focused on leveraging its technology to transition into a comprehensive precision medicine company, aiming to improve cancer treatment through innovative drug development platforms.
